Showing 141 - 160 results of 246 for search '"Southern Illinois University School of Medicine"', query time: 0.17s Refine Results
  1. 141
  2. 142
  3. 143
  4. 144
  5. 145
  6. 146
  7. 147
  8. 148

    Active axial spondyloarthritis: potential role of certolizumab pegol by Ranatunga S, Miller AV

    Published 2014-02-01
    “…Sriya Ranatunga, Anne V Miller Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, IL, USA Abstract: The axial spondyloarthropathies are a group of chronic inflammatory diseases that predominantly affect the axial joints. …”
    Get full text
    Article
  9. 149

    Cetuximab in Refractory Skin Cancer Treatment by Sini J Kalapurakal, James Malone, K. Thomas Robbins, Lucinda Buescher, John Godwin, Krishna Rao

    Published 2012-01-01
    “…</p><p><b>Methods</b>: This is a retrospective study on eight patients who had received cetuximab for treatment of cutaneous carcinoma since 2007 at Southern Illinois University School of Medicine (SIU-SOM) Medical Oncology clinic.…”
    Get full text
    Article
  10. 150
  11. 151
  12. 152
  13. 153

    Prevalence, Impact, and Diagnostic Challenges of Benign Breast Disease: A Narrative Review by Fraker JL, Clune CG, Sahni SK, Yaganti A, Vegunta S

    Published 2023-05-01
    “…Jessica L Fraker,1 Caroline G Clune,2,3,&ast; Sabrina K Sahni,4,&ast; Avani Yaganti,5,&ast; Suneela Vegunta1 1Division of Women’s Health Internal Medicine, Mayo Clinic, Scottsdale, AZ, USA; 2Center for Breast Care, Mayo Clinic Health System — Southwest Wisconsin Region, La Crosse, WI, USA; 3Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA; 4Jacoby Center for Breast Health, Mayo Clinic, Jacksonville, FL, USA; 5Southern Illinois University School of Medicine, Springfield, IL, USA&ast;These authors contributed equally to this workCorrespondence: Jessica L Fraker, Division of Women’s Health Internal Medicine, Mayo Clinic, 13400 E Shea Blvd, Scottsdale, AZ, 85259, USA, Email fraker.jessica@mayo.eduAbstract: Benign breast diseases, which are commonly seen in clinical practice, have various clinical presentations and implications, as well as management strategies. …”
    Get full text
    Article
  14. 154
  15. 155

    Growth hormone and aging: A challenging controversy by Andrzej Bartke

    Published 2008-12-01
    “…Andrzej BartkeGeriatrics Research, Departments of Internal Medicine and Physiology, Southern Illinois University School of Medicine, Springfield, IL, USAAbstract: Although advanced age or symptoms of aging are not among approved indications for growth hormone (GH) therapy, recombinant human GH (rhGH) and various GH-related products are aggressively promoted as anti-aging therapies. …”
    Get full text
    Article
  16. 156
  17. 157
  18. 158

    Update on the use of dutasteride in the management of benign prostatic hypertrophy by Joe Miller, Thomas H Tarter

    Published 2007-04-01
    “…Joe Miller, Thomas H TarterDivision of Urology, Southern Illinois University School of Medicine, Springfield, IL, USAAbstract: Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary symptoms, with a prevalence of 50% by the sixth decade of life. …”
    Get full text
    Article
  19. 159

    Risk of acquired methemoglobinemia with different topical anesthetics during endoscopic procedures by Vallurupalli S, Manchanda S

    Published 2011-07-01
    “…Srikanth Vallurupalli1, Shalini Manchanda21Division of General Internal Medicine, Department of Medicine, Southern Illinois University School of Medicine, Springfield, IL, USA; 2Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USAIntroduction: Methemoglobinemia is a recognized complication of the use of topical anesthetic sprays. …”
    Get full text
    Article
  20. 160